In this context, silencing LACTB can inhibit the metastasis of nasopharyngeal carcinoma by inhibiting ERBB3/EGFR signal transduction and increasing the stability of histone H3 [15]. This evidence concerns the gene EGFR and nasopharyngeal carcinoma.